Science Explorer Back to mapMap
Discussion
Researcher · Modern University for Information and Technology · Egypt

Noha F. Hassan

Noha F. Hassan publishes mostly in Molecular Biology, Epidemiology and Oncology, on topics such as Liver Disease Diagnosis and Treatment, Advanced Glycation End Products research and Quinazolinone synthesis and applications.

ORCID 0000-0003-4095-5437 OpenAlex
World rank
#2,329,120
of 7,710,434 ranked researchers
Rank in Egypt
#6,628
of 36,277
Works
15
Citations
198
Citations per work
13.2
h-index
9
i10-index 8Top 82% in Molecular Biology
Noha F. Hassan

What does Noha F. Hassan research?

Noha F. Hassan's work is mostly in Medicine (24%), Biochemistry, Genetics and Molecular Biology (13%), Pharmacology, Toxicology and Pharmaceutics (7%).

Everything else: 7 works · 48.8% of their workHealth Sciences: 4 works · 24.5% of their workMedicine: 4 works · 24.5% of their workEpidemiology: 2 works · 11.1% of their workOncology: 1 works · 6.7% of their workPharmacology: 1 works · 6.7% of their workLife Sciences: 3 works · 20.0% of their workBiochemistry, Genetics and Molecular Biology: 2 works · 13.3% of their workMolecular Biology: 2 works · 13.3% of their workPharmacology, Toxicology and Pharmaceutics: 1 works · 6.7% of their workPharmacology: 1 works · 6.7% of their workPhysical Sciences: 1 works · 6.7% of their workChemistry: 1 works · 6.7% of their workOrganic Chemistry: 1 works · 6.7% of their workTHEIR WORKNoha F. Hassan15works
Life Sciences20%Physical Sciences7%Health Sciences24%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
  1. Everything else748.8%
    1. Medicine424.5%
    1. Biochemistry, Genetics and Molecular Biology213.3%
    2. Pharmacology, Toxicology and Pharmaceutics16.7%
    1. Chemistry16.7%
  1. 1Molecular Biology13% of their works
  2. 2Epidemiology11% of their works
  3. 3Oncology7% of their works
  4. 4Pharmacology7% of their works
  5. 5Pharmacology7% of their works
  6. 6Organic Chemistry7% of their works

Research topics

Which keywords describe Noha F. Hassan's research?

The keywords of their largest research topics: Diabetes, Inflammation, NAFLD, NASH, Advanced Glycation End Products, Hepatic Encephalopathy, HMGB1 and Indirubin.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 18 words, with their numbers
  1. Diabetes32 topics
  2. Inflammation32 topics
  3. NAFLD31 topic
  4. NASH31 topic
  5. Advanced Glycation End Products21 topic
  6. HMGB121 topic
  7. Hepatic Encephalopathy21 topic
  8. Indirubin21 topic
  9. Liver Cirrhosis21 topic
  10. Quinazoline21 topic
  11. Apiaceae Family11 topic
  12. Bacterial Therapy11 topic
  13. Enzyme Regulation11 topic
  14. Nucleotide Metabolism11 topic
  15. PPARs11 topic
  16. Peroxisome Proliferator-Activated Receptors11 topic
  17. Polyacetylenes11 topic
  18. Tumor Targeting11 topic

Where does Noha F. Hassan work?

Noha F. Hassan's main affiliation in the publication record is Modern University for Information and Technology, Egypt.

How many publications and citations does Noha F. Hassan have?

OpenAlex counts 15 works and 198 citations for Noha F. Hassan, an h-index of 9, ranking #2,329,120 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Noha F. Hassan. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.